Single jab could provide lifelong HIV protection

Lifelong HIV protection could in future be provided by a single injection, US researchers believe.

Ahead of World Aids Day on 1 December, the team from California Institute of Technology published findings of a study of a technique known as vectored immuno-prophylaxis (VIP). This involves using a vector to encode the antibody genes that direct the expression of HIV-neutralising antibodies.

The Californian team showed that mice receiving a single infection seemed to be protected from HIV infection, even when challenged with a high dose of HIV. They believe use of this approach in humans ‘may produce effective prophylaxis against HIV’.

Writing online in Nature, the researchers said: ‘Given the level of protection that VIP has demonstrated in vivo, we believe that highly effective prophylaxis through expression of existing monoclonal antibodies against HIV in humans is achievable.’

Commenting on the findings, Professor Robin Shattock, professor of mucosal infection and immunity at Imperial College in London, said the findings were promising, but ‘much work will be needed to ensure safety, acceptability and efficacy of such an approach for human use’.

‘Nevertheless this study reinforces the potential of neutralising antibodies to prevent HIV infection and complements the drive to develop vaccine approaches designed to induce protective antibodies in at risk individuals,’ he said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs place first orders from government flu jab reserve as £12m support fund rolled out

GPs place first orders from government flu jab reserve as £12m support fund rolled out

GP practices can start ordering flu vaccine from an 8m-dose government stockpile...

Quarter of government's 8m-dose flu stockpile is vaccine granted temporary approval

Quarter of government's 8m-dose flu stockpile is vaccine granted temporary approval

A vaccine yet to be licensed in the UK accounts for more than a quarter of the 8m...

GPs report drop in older patients coming forward with cancer symptoms

GPs report drop in older patients coming forward with cancer symptoms

More than half of GPs say numbers of older patients coming forward with cancer symptoms...

Failure to involve GPs in COVID-19 test and trace 'a disaster and a national shame'

Failure to involve GPs in COVID-19 test and trace 'a disaster and a national shame'

GPs and primary care teams should have played a key role in the UK’s efforts to test,...

RCGP chair 'livid' over attacks on general practice from 'armchair critics'

RCGP chair 'livid' over attacks on general practice from 'armchair critics'

General practice has risen 'heroically' to unprecedented challenges during the COVID-19...

Remote GP consultations a 'lifeline for the NHS' during pandemic, says Hancock

Remote GP consultations a 'lifeline for the NHS' during pandemic, says Hancock

The rapid switch to remote GP consultations during the COVID-19 pandemic provided...